FOXC1: an emerging marker and therapeutic target for cancer
Crossref DOI link: https://doi.org/10.1038/onc.2017.48
Published Online: 2017-03-13
Published Print: 2017-07-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Han, B
Bhowmick, N
Qu, Y
Chung, S
Giuliano, A E
Cui, X
Text and Data Mining valid from 2017-03-13
Version of Record valid from 2017-03-13
Article History
Received: 22 December 2016
Revised: 3 February 2017
Accepted: 4 February 2017
First Online: 13 March 2017
Competing interests
: The authors declare no conflict of interest.